Buprenorphine vs Mirvetuximab Soravtansine

## Buprenorphine vs Mirvetuximab Soravtansine: Overview

This comparison examines the pharmacological differences between **Buprenorphine** and **Mirvetuximab Soravtansine**.

## Mechanism of Action

**Buprenorphine**: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

## Pharmacokinetics

**Half-life**: Buprenorphine — 24-42 hours; Mirvetuximab Soravtansine — N/A.

## Chemical Properties

**Molecular Formula**: Buprenorphine — C29H41NO4; Mirvetuximab Soravtansine — N/A.

**Molecular Weight**: Buprenorphine — 467.6430 g/mol; Mirvetuximab Soravtansine — N/A.

**Type**: Buprenorphine — Small molecule; Mirvetuximab Soravtansine — Antibody drug conjugate.